Sale of generic versions of cancer drug stops as Delhi HC prohibits patent infringement | India News
NEW DELHI: Sale of generic versions of cancer medication Ibrutinib, used to treat leukaemia, has been blocked across the country, denying patients access to affordable therapy.The Delhi high court recently passed an injunction against six domestic companies Natco Pharma, Hetero, BDR Pharma, Shilpa Medicare, Alkem and Laurus Labs from marketing generic versions.The order was passed … Read more
